Pneumonia survivors face hidden heart risks – new study aims to find out why

NCT ID NCT06601998

Recruiting now Knowledge-focused Sponsor: Hellenic Institute for the Study of Sepsis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study follows 650 adults who had pneumonia (including COVID-19) to see how the infection might lead to heart disease later. Researchers will collect blood samples, run heart and lung tests, and track heart attacks, strokes, and other events over three years. No new treatment is being tested; the goal is to better understand the link between lung infections and cardiovascular problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors identify which pneumonia survivors are at higher risk for heart attacks or strokes, and point toward ways to prevent those events.
What could go wrong: This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve health. Results may take years to influence medical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Community-Acquired Pneumonia COVID-19 pneumonia Respiration Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES COVID-19 PNEUMONIA PNEUMONIA, COMMUNITY-ACQUIRED

Contacts and locations

Locations

10th Department of Pulmonary Medicine, Sotiria Athens Hospital of Chest Diseases
RECRUITING

Athens, Greece
1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki
NOT_YET_RECRUITING

Thessaloniki, Greece
1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS
RECRUITING

Athens, Greece
1st Department of Internal Medicine, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S.
RECRUITING

Athens, Greece
1st Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO
RECRUITING

Athens, Greece
1st Department of Internal Medicine, Thriasio General Hospital of Elefsina
NOT_YET_RECRUITING

Elefsina, Greece
1st Intensive Care Clinic of the Medical School of the University of Athens, Evangelismos General Hospital
RECRUITING

Athens, Greece
1st University Department of Internal Medicine, General Hospital of Athens LAIKO
RECRUITING

Athens, Greece
1st University Department of Pulmonary Medicine, Sotiria Athens Hospital of Chest Diseases
RECRUITING

Athens, Greece
2nd Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO
RECRUITING

Athens, Greece
2nd Department of Internal Medicine, University General Hospital of Alexandroupolis
NOT_YET_RECRUITING

Alexandroupoli, Greece
2nd Department of Pulmonary Medicine, Sotiria Athens Hospital of Chest Diseases
RECRUITING

Athens, Greece
3rd University Department of Internal Medicine, Sotiria Athens Hospital of Chest Diseases
RECRUITING

Athens, Greece
4th Department of Internal Medicine, ATTIKON University General Hospital
RECRUITING

Athens, Greece
Intensive Care Unit 2, AHEPA University General Hospital of Thessaloniki
NOT_YET_RECRUITING

Thessaloniki, Greece
Intensive Care Unit, "Ippokrateion" General Hospital of Thessaloniki
NOT_YET_RECRUITING

Thessaloniki, Greece
Intensive Care Unit, General Hospital of Voula ASKLEPIEIO
RECRUITING

Athens, Greece
Out-patients clinic, General Hospital of Voula ASKLEPIEIO
RECRUITING

Athens, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.